1. Kosuge M, Kimura K, Ishikawa T, et al. Prognostic significance of inverted T waves in patients with acute pulmonary embolism. Circ J. 2006. 70:750–755.
2. Yoon NS, Cho JG, Park HW, et al. Usefulness of the 12-lead electrocardiography in the diagnosis and evaluation of severity of pulmonary thromboembolism. Korean Circ J. 2005. 35:389–395.
3. Daniel KR, Courtney DM, Kline JA. Assessment of cardiac stress from massive pulmonary embolism with 12-lead ECG. Chest. 2001. 120:474–481.
4. McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation. 2001. 104:2797–2802.
5. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002. 347:1143–1150.
6. Stein PD, Alshabkhoun S, Hawkins HF, Hyland JW, Jarrett CE. Right coronary blood flow in acute pulmonary embolism. Am Heart J. 1969. 77:356–362.
7. Yoshinaga T, Ikeda S, Shikuwa M, Miyahara Y, Kohno S. Relationship between ECG findings and pulmonary artery pressure in patients with acute massive pulmonary thromboembolism. Circ J. 2003. 67:229–232.
8. Tayama E, Ouchida M, Teshima H, et al. Treatment of acute massive/submassive pulmonary embolism. Circ J. 2002. 66:479–483.
9. Cutforth RH, Oram S. The electrocardiogram in pulmonary embolism. Br Heart J. 1958. 20:41–60.
10. Sreeram N, Cheriex EC, Smeets JL, Gorgels AP, Wellens HJ. Value of the 12-lead electrocardiogram at hospital admission in the diagnosis of pulmonary embolism. Am J Cardiol. 1994. 73:298–303.
11. Iles S, Le Heron CJ, Davies G, Turner JG, Beckert LE. ECG score predicts those with the greatest percentage of perfusion defects due to acute pulmonary thromboembolic disease. Chest. 2004. 125:1651–1656.
12. Kim SE, Park DG, Choi HH, et al. The best predictor for right ventricular dysfunction in acute pulmonary embolism: comparison between electrocardiography and biomarkers. Korean Circ J. 2009. 39:378–381.
13. Chung T, Emmett L, Khoury V, et al. Atrial and ventricular echocardiographic correlates of the extent of pulmonary embolism in the elderly. J Am Soc Echocardiogr. 2006. 19:347–353.
14. Toosi MS, Merlino JD, Leeper KV. Prognostic value of the shock index along with transthoracic echocardiography in risk stratification of patients with acute pulmonary embolism. Am J Cardiol. 2008. 101:700–705.
15. Grewal J, McKelvie RS, Persson H, et al. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol. 2008. 102:733–737.
16. Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA. 2007. 297:169–176.
17. Coutance G, Le Page O, Lo T, Hamon M. Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Crit Care. 2008. 12:R109.
18. ten Wolde M, Tulevski II, Mulder JW, et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation. 2003. 107:2082–2084.